OrthoPediatrics Corp. to Present at the 2021 JMP Securities Life Sciences Conference
OrthoPediatrics Corp (Nasdaq: KIDS) announced participation in the 2021 JMP Securities Life Sciences Conference on June 17, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OrthoPediatrics Corp (Nasdaq: KIDS) announced participation in the 2021 JMP Securities Life Sciences Conference on June 17, 2021. Key executives, including CEO Dave Bailey, COO and CFO Fred Hite, and Executive Chairman Mark Throdahl, will engage in a fireside chat at 12:00pm ET. An audio webcast of the event will be available on the company's investor relations website, with a replay accessible for 90 days post-event. OrthoPediatrics specializes in pediatric orthopedics, offering 36 surgical systems across trauma, scoliosis, and sports medicine.
Details
News Market Reaction – KIDS
The recorded move for KIDS in the trading session of this news was +1.39%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., June 09, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, Chief Executive Officer, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Executive Chairman, are scheduled to participate in the 2021 JMP Securities Life Sciences Conference on Thursday, June 17, 2021.
| Event: | 2021 JMP Securities Life Sciences Conference |
| Format: | Fireside Chat Meeting |
| Date: | Thursday, June 17, 2021 |
| Time: | 12:00pm ET |
An audio webcast of the presentation will be available online at the OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be available for 90 days after the presentation.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 36 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering span trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 45 countries outside the United States. For more information, please visit www.orthopediatrics.com.
Investor Contacts
Matt Bacso, CFA
Gilmartin Group
Matt.bacso@gilmartinir.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.